within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01E_OtherCardiacPreparations.C01EB09_Ubidecarenone;

model Ubidecarenone
  extends Pharmacolibrary.Drugs.ATC.C.C01EB09;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C01EB09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ubidecarenone, also known as coenzyme Q10 (CoQ10) or ubiquinone, is a naturally occurring antioxidant used as a dietary supplement and adjunctive therapy in cardiovascular diseases such as heart failure and angina pectoris. It plays a critical role in mitochondrial electron transport and cellular energy production. While available in some countries as a prescription or over-the-counter product, its approval status for specific indications varies globally.</p><h4>Pharmacokinetics</h4><p>Estimated typical pharmacokinetic parameters for an adult population receiving oral ubidecarenone, as no direct population PK fitting is available in published biomedical literature.</p><h4>References</h4><ol><li><p>Garrido-Maraver, J, et al., &amp; Sanchez-Alcazar, JA (2014). Clinical applications of coenzyme Q10. <i>Frontiers in bioscience (Landmark edition)</i> 19(4) 619–633. DOI:<a href=\"https://doi.org/10.2741/4231\">10.2741/4231</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24389208/\">https://pubmed.ncbi.nlm.nih.gov/24389208</a></p></li><li><p>López-Lluch, G, et al., &amp; Navas, P (2019). Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization. <i>Nutrition (Burbank, Los Angeles County, Calif.)</i> 57 133–140. DOI:<a href=\"https://doi.org/10.1016/j.nut.2018.05.020\">10.1016/j.nut.2018.05.020</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30153575/\">https://pubmed.ncbi.nlm.nih.gov/30153575</a></p></li><li><p>Díaz-Casado, ME, et al., &amp; López, LC (2024). Oral β-RA induces metabolic rewiring leading to the rescue of diet-induced obesity. <i>Biochimica et biophysica acta. Molecular basis of disease</i> 1870(7) 167283–None. DOI:<a href=\"https://doi.org/10.1016/j.bbadis.2024.167283\">10.1016/j.bbadis.2024.167283</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38851305/\">https://pubmed.ncbi.nlm.nih.gov/38851305</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ubidecarenone;
